Accordingly, we hypothesized that the tumor‐suppressive activity of MTAP is mediated through the MTA/PRMT5/protein dimethylation axis, and thus we identified those differentially symmetrically dimethylated proteins in response to MTAP alteration by mass spectrometric analyses. The gene discussed is MTAP; the disease is neoplasm.